Regorafenib (BAY 73-4506): a new oral multikinase inhibitor of angiogenic, stromal and oncogenic receptor tyrosine kinases with potent preclinical antitumor activityWILHELM, Scott M; DUMAS, Jacques; ADNANE, Lila et al.International journal of cancer (Print). 2011, Vol 129, Num 1, pp 245-255, issn 0020-7136, 11 p.Article

Multi-parametric assessment of the anti-angiogenic effects of liposomal glucocorticoidsKLUZA, Ewelina; HEISEN, Marieke; SCHMID, Sophie et al.Angiogenesis (London). 2011, Vol 14, Num 2, pp 143-153, issn 0969-6970, 11 p.Article

Diffusion and perfusion of the kidneyNOTOHAMIPRODJO, Mike; REISER, Maximilian F; SOURBRON, Steven P et al.European journal of radiology. 2010, Vol 76, Num 3, pp 337-347, issn 0720-048X, 11 p.Article

Phase I trial of CYT997, a novel cytotoxic and vascular-disrupting agentLICKLITER, J. D; FRANCESCONI, A. B; WILKS, A et al.British journal of cancer. 2010, Vol 103, Num 5, pp 597-606, issn 0007-0920, 10 p.Article

Quantitative analysis of cytokine-induced vascular toxicity and vascular leak in the mouse brainIRWAN, Yetty Y; YI FENG; GACH, H. Michael et al.Journal of immunological methods. 2009, Vol 349, Num 1-2, pp 45-55, issn 0022-1759, 11 p.Article

Dynamic contrast-enhanced MRI diagnostics in oncology via principal component analysisBRUWER, Mark-John; MACGREGOR, John F; NOSEWORTHY, Michael D et al.Journal of chemometrics. 2008, Vol 22, Num 11-12, pp 708-716, issn 0886-9383, 9 p.Conference Paper

Assessment of MRI and dynamic contrast-enhanced MRI in the differential diagnosis of adenomatoid odontogenic tumorASAUMI, Jun-Ichi; YANAGI, Yoshinobu; KONOUCHI, Hironobu et al.European journal of radiology. 2004, Vol 51, Num 3, pp 252-256, issn 0720-048X, 5 p.Article

The clinical value of dynamic contrast-enhanced magnetic resonance imaging at 3.0T to detect prostate cancerXUHUI ZHANG; XIANYUE QUAN; SHILONG LU et al.Journal of international medical research. 2014, Vol 42, Num 5, pp 1173-1180, issn 0300-0605, 8 p.Article

Dynamic contrast-enhanced magnetic resonance imaging for estimating tumor proliferation and microvessel density of oral squamous cell carcinomasUNETSUBO, Teruhisa; KONOUCHI, Hironobu; YANAGI, Yoshinobu et al.Oral oncology (1997). 2009, Vol 45, Num 7, pp 621-626, issn 1368-8375, 6 p.Article

Moderne MR-Verfahren zur Beurteilung der Tumorresponse : Tumorresponse = Modern magnetic resonance procedures for assessing tumor responsePERSIGEHL, T; HEINDEL, W; BREMER, C et al.Der Radiologe (Berlin. Print). 2008, Vol 48, Num 9, pp 863-870, issn 0033-832X, 8 p.Article

A simple, reproducible method for monitoring the treatment of tumours using dynamic contrast-enhanced MR imagingMORGAN, B; UTTING, J. F; HIGGINSON, A et al.British journal of cancer. 2006, Vol 94, Num 10, pp 1420-1427, issn 0007-0920, 8 p.Article

Tumour response prediction by diffusion-weighted MR imaging: Ready for clinical use?HEIJMEN, Linda; VERSTAPPEN, Maartje C. H. M; TER VOERT, Edwin E. G. W et al.Critical reviews in oncology/hematology. 2012, Vol 83, Num 2, pp 194-207, issn 1040-8428, 14 p.Article

DCE-MRI using small-molecular and albumin-binding contrast agents in experimental carcinomas with different stromal content : Imaging diseases of the female pelvis SIFARACE, Paolo; MERIGO, Flavia; FIORINI, Silvia et al.European journal of radiology. 2011, Vol 78, Num 1, pp 52-59, issn 0720-048X, 8 p.Article

Correlation of a priori DCE-MRI and ¹H-MRS data with molecular markers in neck nodal metastases: Initial analysisJANSEN, Jacobus F. A; CARLSON, Diane L; SHAH, Jatin P et al.Oral oncology (1997). 2012, Vol 48, Num 8, pp 717-722, issn 1368-8375, 6 p.Article

Inhibition of tyrosine kinase receptors by SU6668 promotes abnormal stromal development at the periphery of carcinomasFARACE, P; GALIE, M; MERIO, F et al.British journal of cancer. 2009, Vol 100, Num 10, pp 1575-1580, issn 0007-0920, 6 p.Article

Differentiation of infective from neoplastic brain lesions by dynamic contrast-enhanced MRIHARIS, Mohammad; RAKESH KUMAR GUPTA; SINGH, Anup et al.Neuroradiology (Berlin. Print). 2008, Vol 50, Num 6, pp 531-540, issn 0028-3940, 10 p.Article

Effects of platinum/taxane based chemotherapy on acute perfusion in human pelvic tumours measured by dynamic MRILANKESTER, K. J; TAYLOR, N. J; STIRLING, J. J et al.British journal of cancer. 2005, Vol 93, Num 9, pp 979-985, issn 0007-0920, 7 p.Article

A Phase IA, Open-label, Dose-escalating Study of PTK787/ZK 222584 Administered Orally on a Continuous Dosing Schedule in Patients with Advanced CancerDREVS, Joachim; MEDINGER, Michael; LAURENT, Dirk et al.Anticancer research. 2010, Vol 30, Num 6, pp 2335-2339, issn 0250-7005, 5 p.Article

Significance of Breast Lesion Descriptors in the ACR BI-RADS MRI LexiconAGRAWAL, Garima; SU, Min-Ying; NALCIOGLU, Orhan et al.Cancer. 2009, Vol 115, Num 7, pp 1363-1380, issn 0008-543X, 18 p.Article

DCE-MRI in clinical trials: data acquisition techniques and analysis methodsSTRECKER, R; SCHEFFLER, K; BÜCHERT, M et al.International journal of clinical pharmacology and therapeutics. 2003, Vol 41, Num 12, pp 603-605, issn 0946-1965, 3 p.Article

Liver Perfusion Changes Occurring During Pancreatic Islet Engraftment: A Dynamic Contrast-Enhanced Magnetic Resonance StudyESPOSITO, A; PALMISANO, A; DEL MASCHIO, A et al.American journal of transplantation (Print). 2014, Vol 14, Num 1, pp 202-209, issn 1600-6135, 8 p.Article

Magnetic resonance imaging of hypoxic injury to the murine placentaTOMLINSON, Tracy M; GARBOW, Joel R; ANDERSON, Jeff R et al.American journal of physiology. Regulatory, integrative and comparative physiology. 2010, Vol 67, Num 2, issn 0363-6119, R312-R319Article

Promise and progress for functional and molecular imaging of response to targeted therapies : Molecular imagingSTEPHEN, Renu M; GILLIES, Robert J.Pharmaceutical research. 2007, Vol 24, Num 6, pp 1172-1185, issn 0724-8741, 14 p.Article

Application of dynamic contrast-enhanced MRI to differentiate malignant lymphoma from squamous cell carcinoma in the head and neckASAUMI, Jun-Ichi; YANAGI, Yoshinobu; KONOUCHI, Hironobu et al.Oral oncology (1997). 2004, Vol 40, Num 6, pp 579-584, issn 1368-8375, 6 p.Article

A phase 1 trial of intravenous 4-(N-(S-glutathionylacetyl)amino) phenylarsenoxide (GSAO) in patients with advanced solid tumoursHORSLEY, Laura; CUMMINGS, Jeff; HALFORD, Sarah et al.Cancer chemotherapy and pharmacology. 2013, Vol 72, Num 6, pp 1343-1352, issn 0344-5704, 10 p.Article